ArticleNPJ digital medicine2026
Forecasting Alzheimer's disease progression via identity-preserved denoising diffusion generative adversarial network.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Forecasting the progression of Alzheimer's disease (AD) is essential for evaluating secondary prevention measures thought to modify the disease trajectory. However, accurate prediction of longitudinal MRIs remains challenging, particularly in preserving subject identity, as deep generative models may potentially generate plausible future MRIs of different individuals from a single baseline scan. In the present study, we developed a novel identity-preserved denoising diffusion generative adversarial network (IP-DDGAN) capable of rapidly generating subject-specific longitudinal MRIs conditioned on metadata. Concretely, we developed an identity-preservation strategy incorporating a metadata-guided module and identity-preserved regularization terms to maintain subject identity in synthetic longitudinal MRIs. Furthermore, we comprehensively integrated morphometric, subject-identity-consistency, and image-level quality metrics to evaluate the fidelity and biological plausibility of synthetic longitudinal MRIs. The results demonstrate that the synthetic MRIs generated by IP-DDGAN retain biological and disease-related phenotypes and exhibit sufficient realism to support downstream applications. Our proposed model effectively captures temporal biological and disease-related changes and predicts distinct disease progression trajectories, including the clinically important transitions from cognitively normal (CN) to mild cognitive impairment (MCI) and from MCI to AD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.